2022 annual financial data
Nurix Therapeutics, Inc. 2022 Operating margin
Nurix Therapeutics, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was -476.01%.
Operating income was -183,867,000 USD and net income was -166,045,000 USD.
Operating cash flow was -159,807,000 USD.
Get free Nurix Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,627,000 USD
- Operating income
- -183,867,000 USD
- Net income
- -166,045,000 USD
- Operating cash flow
- -159,807,000 USD